CLINICAL PHARMACOKINETIC STUDIES OF TETRA(META-HYDROXYPHENYL)CHLORIN IN SQUAMOUS-CELL CARCINOMA BY FLUORESCENCE SPECTROSCOPY AT 2 WAVELENGTHS

被引:46
作者
BRAICHOTTE, D
SAVARY, JF
GLANZMANN, T
WESTERMANN, P
FOLLI, S
WAGNIERES, G
MONNIER, P
VANDENBERGH, H
机构
[1] CHU VAUDOIS, SERV OTORHINOLARYNGOL, CH-1011 LAUSANNE, SWITZERLAND
[2] UNIV LAUSANNE, INST BIOCHIM, CH-1066 EPALINGES, SWITZERLAND
关键词
D O I
10.1002/ijc.2910630209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To optimize photodynamic therapy (PDT) and photodetection of cancer with second-generation photosensitizers, knowledge of important variables such as the uptake of the dye and the dye contrast between normal and tumoral tissue after injection is necessary. The pharmacokinetics of a second-generation photosensitizer, tetra(meta-hydroxyphenyl) chlorin (mTHPC), is presented. To study this in a clinical context, an apparatus based on fluorescence spectroscopy and a noninvasive optical fiber probe has been used. The mTHPC fluorescence is induced at 2 excitation wavelengths (420 and 520 nm) with different penetration depth. The pharmacokinetics of mTHPC in patients with a squamous-cell carcinoma in the oral cavity show a signal selectivity as high as 16 about 3 hr after i.v. injection for the more advanced carcinomas. The magnitude of this selectivity appears to correlate with the staging of the cancer, the more invasive tumors showing the highest selectivity. Results obtained at 420 and 520 nm show little difference. These pharmacokinetics can be used directly for optimizing photodetection with mTHPC. However, complementary information on the localization of the drug by fluorescence microscopy, and a correlation of this data with tumor necrosis efficacy, are needed to optimize PDT timing. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 22 条
[1]   A FLUORESCENCE IMAGING DEVICE FOR ENDOSCOPIC DETECTION OF EARLY STAGE CANCER - INSTRUMENTAL AND EXPERIMENTAL STUDIES [J].
BAUMGARTNER, R ;
FISSLINGER, H ;
JOCHAM, D ;
LENZ, H ;
RUPRECHT, L ;
STEPP, H ;
UNSOLD, E .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1987, 46 (05) :759-763
[2]  
BEAHRS OH, 1992, MANUAL STAGING CANCE
[3]   SELECTIVITY OF MESO-TETRA(HYDROXYPHENYL)PORPHYRINS AND CHLORINS AND OF PHOTOFRIN-II IN CAUSING PHOTODAMAGE IN TUMOR, SKIN, MUSCLE AND BLADDER - THE CONCEPT OF COST-BENEFIT IN ANALYZING THE RESULTS [J].
BERENBAUM, MC ;
BONNETT, R ;
CHEVRETTON, EB ;
AKANDEADEBAKIN, SL ;
RUSTON, M .
LASERS IN MEDICAL SCIENCE, 1993, 8 (04) :235-243
[4]   HYDROPORPHYRINS OF THE MESO-TETRA(HYDROXYPHENYL)PORPHYRIN SERIES AS TUMOR PHOTOSENSITIZERS [J].
BONNETT, R ;
WHITE, RD ;
WINFIELD, UJ ;
BERENBAUM, MC .
BIOCHEMICAL JOURNAL, 1989, 261 (01) :277-280
[5]   PHOTOBLEACHING OF PHOTOFRIN-II AS A MEANS OF ELIMINATING SKIN PHOTOSENSITIVITY [J].
BOYLE, DG ;
POTTER, WR .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1987, 46 (06) :997-1001
[6]  
BRAICHOTTE D, 1995, P SOC PHOTO-OPT INS, V2371, P120
[7]  
BRAICHOTTE D, 1992, INT CONGR SER, V1011, P883
[8]  
BRAICHOTTE DR, 1995, CANCER, V75, P2768, DOI 10.1002/1097-0142(19950601)75:11<2768::AID-CNCR2820751122>3.0.CO
[9]  
2-I
[10]  
BROWN SB, 1992, INT CONGR SER, V1011, P475